Cargando…
The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group Design
Background: Despite rapid advances in research on Parkinson's disease (PD), in particular in the elucidation of genetic contributions, no disease-modifying therapy has become available to date. Objectives: In the proposed project, we aim to investigate the potential effects of vitamin K2 (long-...
Autores principales: | Prasuhn, Jannik, Kasten, Meike, Vos, Melissa, König, Inke R., Schmid, Sebastian M., Wilms, Britta, Klein, Christine, Brüggemann, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829299/ https://www.ncbi.nlm.nih.gov/pubmed/33505346 http://dx.doi.org/10.3389/fneur.2020.592104 |
Ejemplares similares
-
An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial
por: Prasuhn, Jannik, et al.
Publicado: (2019) -
Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease
por: Prasuhn, Jannik, et al.
Publicado: (2022) -
Genotype-driven therapeutic developments in Parkinson’s disease
por: Prasuhn, Jannik, et al.
Publicado: (2021) -
Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
por: Prasuhn, Jannik, et al.
Publicado: (2021) -
Applicability of optical coherence tomography angiography (OCTA) imaging in Parkinson’s disease
por: Lauermann, Jost L., et al.
Publicado: (2021)